Lazare Rivière (1589-1655 AD), the Pioneer Pharmacologist, Anatomist, and Surgeon, Who Gave the First Modern Description of an Aortic Valve Failure

Σγάντζος, Μάρκος; Tsoucalas, Gregory; Markatos, Konstantinos; Giatsiou, Styliani; Androutsos, George

doi:10.1177/1553350615577482

Cited by 2 publications

(2 citation statements)

References 8 publications

(8 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The history of aortic valve stenosis is one that spans centuries, as well as species. The pathological process of stenosis, as associated with the aortic valve, was first described in 1663 by Lazare Riviere, a physician who likened the lesions to both carbuncles and hazelnuts and, building upon a Galenic theory of valvular development, suggested that the lesions “hardened by the heat of the heart and changed their substance” [ 11 - 13 ]. In fact, it is credited as the first necropsy-based description of aortic valve pathology [ 11 ].…”

Section: Sas Through the Centuriesmentioning

confidence: 99%

Subvalvular Aortic Stenosis: Learning From Human and Canine Clinical Research

Crofton,

Kovacs,

Stern

2023

Cardiol Res

View full text Add to dashboard Cite

Subvalvular aortic stenosis (SAS) is the most common congenital heart disease (CHD) in dogs and is also prevalent in human children. A fibrous ridge below the aortic valve narrows the left ventricular outflow tract (LVOT) and increases blood flow velocity, leading to devastating side effects in diseased patients. Due to the similarities in presentation, anatomy, pathophysiology, cardiac development, genomics, and environment between humans and dogs, canine SAS patients represent a critical translational model of human SAS. Potential adverse outcomes of SAS include arrhythmias, left-sided congestive heart failure, endocarditis, exercise intolerance, syncope, and sudden cardiac death. The greatest divergence between canine and human SAS clinical research has been the standard of care regarding treatment of these outcomes, with pharmacological intervention dominating best practices in veterinary medicine and surgical intervention comprising the standard practice for human SAS patients. Regardless of the species, the field has yet to identify a treatment option to prevent disease progression or permanently remove the fibrous ridge, but historical leaps in SAS research support a continued translational approach as the most promising method for achieving this goal.

show abstract

Section: Sas Through the Centuriesmentioning

confidence: 99%

Subvalvular Aortic Stenosis: Learning From Human and Canine Clinical Research

Crofton,

Kovacs,

Stern

2023

Cardiol Res

View full text Add to dashboard Cite

show abstract

“…Prvi prikaz bolesnika sa infektivnim endokarditisom (IE) aortne valvule datira iz 1646. godine 1 . Jean Nicolas Corvisart je 1806. godine upotrebio termin vegetacija, 1835. godine Jean Batist Bujo je uveo termin endokard, a zatim je usledila i upotreba termina endokarditis 2,3 .…”

Section: Uvodunclassified

Infective endocarditis

Ivanović¹

2022

Galenika Med J

View full text Add to dashboard Cite

Infective endocarditis (IE) was first described more than 350 years ago. It is a disease of the endocardial surface of the heart. Infection typically involves the cardiac valves (native or prosthetic) or an indwelling cardiac device. The cardiac manifestations could include valvular vegetation, abscess, periannular extension of infection. The clinical manifestations of IE are protean and can involve all organic system. Early clinical suspicion and rapid diagnosis are crucial for adequate treatment and reduction of complications and mortality. Integrating clinical results, imaging, and biomarkers are traditionally applied in suspected IE modified Duke criteria. New imaging technologies, such as multi-slice computed tomography, photon-emission computed tomography, and magnetic resonance imaging, might add value to conventional echocardiography in diagnosis and management of IE. Complications from IE are common, and include congestive heart failure, embolism, septic shock, invasive infection, prosthetic valve dehiscence, heart block, and mycotic aneurysm. Intravenous antibiotics are first-line therapy with cardiac surgery being reserved for certain complications of IE and/or for clinical situations in which there is a high risk of complications. Longstanding controversies such as the timing of surgery or the role of antibiotic prophylaxis have not been resolved.

show abstract

Lazare Rivière (1589-1655 AD), the Pioneer Pharmacologist, Anatomist, and Surgeon, Who Gave the First Modern Description of an Aortic Valve Failure

Cited by 2 publications

References 8 publications

Subvalvular Aortic Stenosis: Learning From Human and Canine Clinical Research

Subvalvular Aortic Stenosis: Learning From Human and Canine Clinical Research

Infective endocarditis

Contact Info

Product

Resources

About